Martingale Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,806
| Closed | -$374K | – | 876 |
|
|
2022
Q1 | $374K | Sell |
13,806
-3,700
| -21% | -$100K | 0.01% | 693 |
|
|
2021
Q4 | $396K | Sell |
17,506
-100
| -0.6% | -$2.26K | 0.01% | 687 |
|
|
2021
Q3 | $463K | Buy |
17,606
+10,100
| +135% | +$266K | 0.01% | 683 |
|
|
2021
Q2 | $241K | Hold |
7,506
| – | – | ﹤0.01% | 768 |
|
|
2021
Q1 | $265K | Sell |
7,506
-100
| -1% | -$3.53K | ﹤0.01% | 770 |
|
|
2020
Q4 | $245K | Sell |
7,606
-29,900
| -80% | -$963K | ﹤0.01% | 791 |
|
|
2020
Q3 | $1.41M | Buy |
+37,506
| New | +$1.41M | 0.02% | 523 |
|